100 likes | 264 Views
AML1/Runx1 and oncogenic transformation . RUNT domain (DNA BINDING). Chr 21. Chr 8. 4 Nervy repressor domains. Translocation (8;21). In human myeloid leukemia =>. RUNT domain. 4 Nervy repressor domains. Lozenge Drosophila. Runt Drosophila. Runx D.rerio. Runx1 G.gallus.
E N D
AML1/Runx1 and oncogenic transformation RUNT domain (DNA BINDING) Chr 21 Chr 8 4 Nervy repressor domains Translocation (8;21) In human myeloid leukemia => RUNT domain 4 Nervy repressor domains
Lozenge Drosophila Runt Drosophila Runx D.rerio Runx1 G.gallus RUNX1v2 H.sapiens Runx1 R.norvegicus 0.1 Runx1 M.musculus Mcoffee: multiple sequence alignment and phylogenetic tree RUNX1 alignment
(Drosophila) NO alignment between species for the t(8;21)
Is there a difference between the proteinic folding of AML1 and AML1-ETO??
Predicted structures of AML1-ETO domains NCBI- BLAST RUNT Zf NRH2 domain PDB- models database
Phosphorylation site? Phosphorylation site? AML1-ETO: hydrophobic cluster analysis with drawhca Runt TAFH(NHR1) NHR2 NHR3 zf-NHR4
Conclusions: • Biocomputing study of AML-1 ETO • Sequences comparison vs AML-1 • 3D prediction • Hydrophobic domains prediction • Potential phosphorylation sites of AML1 Comparison with AML1-ETO
.....and now you have to return to the lab and make experiments...........